Variety and intensity of emotions in nightmares and bad dreams

The Journal of Nervous and Mental Disease
Antonio ZadraD C Donderi

Abstract

Nightmares are usually defined as frightening dreams that awaken the sleeper. This study uses the waking criterion to distinguish between nightmares and bad dreams and investigated the variety and intensity of emotions reported in each form of disturbing dream. Ninety participants recorded their dreams for 4 consecutive weeks and, for each dream recalled, noted the emotions present and their intensities on a 9-point scale. Thirty-six participants reported at least one nightmare and one bad dream over the 4 weeks covered by the log, while 29 reported having had at least one bad dream but no nightmares. Nightmares were rated as being significantly (p < 0.001) more intense than bad dreams. Thirty percent of nightmares and 51% of bad dreams contained primary emotions other than fear. The findings support the claim that awakening can serve as an indirect measure of nightmare intensity and raise important implications for the operational definition of nightmares.

Associated Clinical Trials

References

Oct 1, 1979·The American Journal of Psychiatry·E O BixlerS Healey
Jan 1, 1978·Psychotherapy and Psychosomatics·H L Levitan
Jan 1, 1976·Psychotherapy and Psychosomatics·H L Levitan
Feb 1, 1990·Journal of Abnormal Psychology·J M Wood, R R Bootzin
Jul 1, 1971·The Journal of Nervous and Mental Disease·M Hersen
Nov 1, 1966·Proceedings of the Society for Experimental Biology and Medicine·C E Hall, O Hall
Oct 1, 1980·The American Journal of Psychiatry·A KalesR Cadieux
Sep 1, 1995·Behaviour Research and Therapy·B KrakowL Lambert
Jan 13, 1999·Perceptual and Motor Skills·A L ZadraD C Donderi
Sep 25, 2003·European Archives of Psychiatry and Clinical Neuroscience·Michael Schredl
Jun 4, 2004·Journal of Sleep Research·Mark BlagroveElvira Williams

❮ Previous
Next ❯

Citations

Mar 17, 2010·European Archives of Psychiatry and Clinical Neuroscience·Michael Schredl
Apr 25, 2012·European Archives of Psychiatry and Clinical Neuroscience·Péter SimorRóbert Bódizs
Mar 13, 2009·Child Psychiatry and Human Development·Michael SchredlGerd Lehmkuhl
Aug 18, 2009·The Journal of Nervous and Mental Disease·Ross LevinStuart Spendlove
Sep 3, 2013·The Journal of Nervous and Mental Disease·Mylène DuvalAntonio Zadra
Aug 24, 2011·The Australian and New Zealand Journal of Psychiatry·Andrea J PhelpsMark Creamer
Aug 12, 2014·Pathologie-biologie·A GauchatA Zadra
Oct 11, 2012·Sleep Medicine Reviews·Aslak Wøien AugedalStåle Pallesen
Feb 18, 2010·Sleep Medicine Clinics·Brant Hasler, Anne Germain
May 5, 2009·Schizophrenia Research·Félix-Antoine LusignanRoger Godbout
Dec 25, 2015·SpringerPlus·Maria Francisca RegoRui Nunes
May 17, 2008·Journal of Sleep Research·Geneviève Robert, Antonio Zadra
Sep 25, 2015·Borderline Personality Disorder and Emotion Dysregulation·Franc PaulGeorg W Alpers
May 15, 2007·Sleep Medicine Reviews·Tore Nielsen, Ross Levin
Feb 6, 2014·Sleep·Geneviève Robert, Antonio Zadra
Oct 18, 2014·Sleep·Nils SandmanTiina Paunio
Jun 18, 2017·Frontiers in Neurology·Tore Nielsen
Jul 26, 2018·Journal of Clinical Psychology in Medical Settings·Westley A YoungrenJoanne L Davis
Jan 1, 2010·Sleep·Delphine OudietteIsabelle Arnulf
Nov 5, 2020·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Ruda LeeSooyeon Suh
Nov 13, 2020·Frontiers in Psychology·Brigitte HolzingerGerhard Klösch
Nov 28, 2020·Physiology & Behavior·Lenka Martinec NovákováJitka Bušková

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.